A child with valproic acid-associated carnitine deficiency and carnitine-responsive cardiac dysfunction.
Valproic acid enhances renal losses of carnitine esters and leads to decreased plasma free carnitine concentrations in many patients receiving valproic acid therapy. However, decreased serum carnitine levels are of unclear pathologic significance, and most children manifest no symptoms of carnitine deficiency. We report a child with valproic acid-associated carnitine deficiency who had severe cardiac dysfunction develop that resolved with carnitine replacement therapy.
D002331:Carnitine / Q000032:analysis / Q000172:deficiency* / Q000378:metabolism; D002648:Child; D002658:Developmental Disabilities / Q000150:complications / Q000378:metabolism; D006331:Heart Diseases / Q000150:complications / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008659:Metabolic Diseases / Q000150:complications; D009206:Myocardium / Q000378:metabolism; D014635:Valproic Acid / Q000009:adverse effects*
D014635:Valproic Acid; D002331:Carnitine